Your session is about to expire
← Back to Search
High Dose Hemp Fiber Bar for Gastrointestinal Dysfunction
Study Summary
This trial aims to investigate the potential benefits of two compounds found in hemp seed shells, called N-trans-caffeoyl tyramine (NCT) and N-trans-feruloyl ty
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is there an age restriction that excludes individuals who are 60 years old or older from participating in this clinical trial?
"To be eligible for this research study, participants must fall within the age range of 18 to 65 years old."
Are new patients currently being enrolled in this ongoing medical study?
"As per the information provided on clinicaltrials.gov, this ongoing clinical trial is actively seeking eligible participants. The initial posting of the trial occurred on December 9th, 2023, and it was most recently updated on January 11th, 2024."
What specific criteria must individuals meet to be eligible for enrollment in this clinical study?
"In order to be eligible for participation in this research, individuals must possess metabolic disorders and fall between the ages of 18 and 65. Around 27 subjects are being sought during the recruitment phase of this clinical trial."
What is the total number of individuals currently under research in this clinical trial?
"Indeed, according to the details available on clinicaltrials.gov, this clinical trial is actively seeking eligible participants. The initial posting of the trial took place on December 9th, 2023 and it was last updated on January 11th, 2024. There is a target of enrolling a total of 27 participants across one study site."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger